|
Hahm, H A; Armstrong, D K; Chen, T L et al. (2000) Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: a phase 2 study. Biol Blood Marrow Transplant 6:335-43
|
|
Gore, S D; Rowinsky, E K; Miller, C B et al. (1998) A phase II ""window"" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia. Clin Cancer Res 4:2677-89
|
|
Chen, T L; Kennedy, M J; Anderson, L W et al. (1997) Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation. Drug Metab Dispos 25:544-51
|
|
O'Reilly, S; Donehower, R C; Rowinsky, E K et al. (1996) A phase II trial of topotecan in patients with previously untreated pancreatic cancer. Anticancer Drugs 7:410-4
|
|
Anderson, L W; Chen, T L; Colvin, O M et al. (1996) Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy. Clin Cancer Res 2:1481-7
|
|
Kaufmann, S H; Gore, S D; Letendre, L et al. (1996) Factors affecting topotecan sensitivity in human leukemia samples. Ann N Y Acad Sci 803:128-42
|
|
Passos-Coelho, J L; Ross, A A; Kahn, D J et al. (1996) Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor. J Clin Oncol 14:2569-75
|
|
Chen, T L; Passos-Coelho, J L; Noe, D A et al. (1995) Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation. Cancer Res 55:810-6
|
